SELLAS Life Sciences (SLS) Return on Invested Capital (2013 - 2017)

SELLAS Life Sciences (SLS) reported Return on Invested Capital of 0.01% for Q4 2017, down 525.11% quarter-over-quarter from 0.0% in Q3 2017.

SELLAS Life Sciences (SLS) Return on Invested Capital (2013 - 2017) Analysis & Trends

SELLAS Life Sciences (SLS) has 3 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2017.

  • Return on Invested Capital for Q4 2017 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was 0.01% (changed N/A YoY), and the FY2021 annual result was 0.01%, changed 0.0% from the prior year.
  • Return on Invested Capital slipped to 0.01% in Q4 2017 per SLS's latest filing, from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q3 2017 and troughed at 0.01% in Q3 2014.
  • A 3-year average of 0.01% and a median of 0.01% in 2014 frame the typical range for Return on Invested Capital.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.01%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -0.01%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -0.01%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.00%
9 Abivax 91.96 Bn 91.96 Bn - -
10 SELLAS Life Sciences 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2017 -0.01%
Sep 30, 2017 0.00%
Jun 30, 2017 0.00%
Sep 30, 2014 -0.01%
Jun 30, 2014 -0.01%
Mar 31, 2014 -0.01%
Dec 31, 2013 -0.01%